REQUEST A DEMO
Total
USD $0.00
Search more companies

Everest Swiss Pharm Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: All Other Food Manufacturing | Perishable Prepared Food Manufacturing | All Other Miscellaneous Food Manufacturing | Soft Drink Manufacturing | Medical Equipment and Supplies Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Department Stores | Other Direct Selling Establishments
Full name: Everest Swiss Pharm Sp. z o.o. Profile Updated: May 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Everest Swiss Pharm Sp. z o.o. is a company based in Poland, with its head office in Bialystok. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was established on January 25, 2019. Its’ total assets recorded a negative growth of 0.39%.

Headquarters
Ul. Warszawska 6/32
Bialystok; Podlaskie; Postal Code: 15-063

Contact Details: Purchase the Everest Swiss Pharm Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Everest Swiss Pharm Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Everest Swiss Pharm Sp. z o.o. report to view the information.
Incorporation Date:
January 25, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Everest Swiss Pharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total Operating Revenue
-100%
Operating Profit
77.45%
EBITDA
77.45%
Net Profit/Loss for the Period
77.45%
Total Assets
-0.39%
Total Equity
-0.34%
Return on Equity (ROE)
-1.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?